PKI 14-22 amide,myristoylated TFA |
Katalog-Nr.GC61849 |
PKI 14-22 Amid, myristoyliertes TFA ist ein potenter cAMP-abhÄngiger PKA-Inhibitor. PKI 14-22 Amid, myristoyliertes TFA reduziert die IgG-vermittelte phagozytische Antwort und hemmt auch die AdhÄsion von Neutrophilen.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
PKI 14-22 amide,myristoylated TFA is a potent cAMP-dependent PKA inhibitor. PKI 14-22 amide,myristoylated TFA reduces the IgG-mediated phagocytic response and also inhibits neutrophil adhesion[1].
References:
[1]. L Ydrenius, et al. Activation of cAMP-dependent protein kinase is necessary for actin rearrangements in human neutrophils during phagocytosis. J Leukoc Biol. 2000 Apr;67(4):520-8.
Average Rating: 5
(Based on Reviews and 16 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *